How Cox was paid
$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| John G. CoxPresident and Chief Executive Officer | $721,000 | — | $937,893 | $410,970 | $7,005 | $2,076,868 |
| Erick LuceraChief Financial Officer | $391,970 | $691,406 | $1,408,214 | $197,600 | $6,796 | $2,695,986 |
| Johanna Friedl-NadererChief Commercial Officer | $610,691 | — | $243,666 | $232,063 | — | $1,086,420 |
| Douglas KerrChief Medical Officer | $537,000 | — | $309,533 | $204,060 | $7,005 | $1,057,598 |
| Richard ScalzoFormer Senior Vice President, Head of Finance and Administration | $107,500 | $166,773 | $106,335 | — | $347,030 | $727,638 |
| Oxana BeskrovnayaChief Innovation Officer, Former Chief Scientific Officer | $531,500 | — | $252,153 | $201,970 | $7,005 | $992,628 |
What changed and why
- $2.1MJohn G. Cox received total compensation of $2,076,868 in fiscal 2025.
- The CEO to median employee pay ratio was 6:1 for fiscal 2025.
- $339KThe median annual total compensation of employees was $338,650.
- Performance-based stock options and annual cash incentives were utilized to reward performance.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.